- 352 pages
- English
- PDF
- Available on iOS & Android
eBook - PDF
About this book
Worldwide, Ovarian carcinoma continues to be responsible for more deaths than all other gynecologic malignancies combined. International leaders in the field address the critical biologic and basic science issues relevant to the disease. The book details the molecular biological aspects of ovarian cancer. It provides molecular biology techniques of understanding this cancer. The techniques are designed to determine tumor genetics, expression, and protein function, and to elucidate the genetic mechanisms by which gene and immunotherapies may be perfected. It provides an analysis of current research into aspects of malignant transformation, growth control, and metastasis. A comprehensive spectrum of topics is covered providing up to date information on scientific discoveries and management considerations.
Frequently asked questions
Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Ovarian Cancer by Samir A. Farghaly in PDF and/or ePUB format, as well as other popular books in Medicine & Gynecology, Obstetrics & Midwifery. We have over one million books available in our catalogue for you to explore.
Information
Table of contents
- Ovarian Cancer - Clinical and Therapeutic Perspectives
- Contents
- Preface
- Chapter 1 Ovarian Cancer Incidence: Current and Comprehensive Statistics
- Chapter 2 Preventive Strategies in Epithelial Ovarian Cancer
- Chapter 3 Screening for Ovarian Cancer in Women
- Chapter 4 Borderline and Malignant Surface Epithelial – Stromal Tumors of the Ovary
- Chapter 5 Central Nervous System Involvement from Epithelial Ovarian Cancer
- Chapter 6 Peripheral Neuropathy in Ovarian Cancer
- Chapter 7 Therapeutic Strategies in Ovarian Cancer
- Chapter 8 Combined Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for the Treatment of Advanced Ovarian Cancer
- Chapter 9 Minimally Invasive Surgical Procedures for Patients with Advanced and Recurrent Ovarian Cancer
- Chapter 10 Management of Recurrent or Persistent Ovarian Cancer
- Chapter 11 Antiprogestins in Ovarian Cancer
- Chapter 12 Intraperitoneal Radionuclide Therapy – Clinical and Pre-Clinical Considerations
- Chapter 13 Vitamin K2 as a Chemotherapeutic Agent for Treating Ovarian Cancer
- Chapter 14 Second-Line Chemotherapy for Platinum- and Taxane-Resistant Epithelial Ovarian Cancer: Pegylated Liposomal Doxorubicin (PLD), Irinotecan, and Combination Therapies at Lower Doses
- Chapter 15 HER2 as a Therapeutic Target in Ovarian Cancer
- Chapter 16 Sexuality After Ovarian Cancer Therapy
- Chapter 17 Quality of Life of Patients with Ovarian Cancer